At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
03696 INSILICO
Not Yet Opened 07-17 16:08:11
43.200
-5.820
-11.87%
High49.800
Low42.740
Vol21.78M
Open49.280
D1 Closing49.020
Amplitude14.40%
Mkt Cap25.01B
Tradable Cap25.01B
Total Shares579.00M
T/O966.13M
T/O Rate3.76%
Tradable Shares579.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Movement Alert｜Insilico Medicine Falls 5.26% in Regular Trading, Trading at HK$45.22
Movement Alert｜Insilico Medicine Rises 5.09% in Regular Trading, Strategic CNS Collaboration With Concord Pharma Worth Up to RMB 1.2 Billion in Milestones
InSilico Medicine Cayman TopCo is a company principally engaged in the artificial intelligence (AI)-driven drug discovery and pipeline development business. The Company mainly self-develops drug candidates, co-develops and partially retains certain intellectual property (IP) rights for out-licensed drugs as well as collaborates with other pharmaceutical companies without retaining any IP rights. The Company generated several clinical or IND-enabling stage assets using its own AI platform under the name of Pharma.AI. The Company is also engaged in software solutions and other discovery business related to non-pharma sectors.